Tudor Investment Corporation »

Compass Therapeutics shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $470k 89k 5.29

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
State Street SPDR S&P 500 ETF Trust - US ETP ETF Option Call Option (SPY)
Spdr Gold Shares - US ETP ETF Option Call Option (GLD)
Nvidia Corp - US Equity (NVDA)
State Street Energy Select Sector SPDR ETF - US ET ETF Option Call Option (XLE)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Microsoft Corp - US Equity (MSFT)
State Street Financial Select Sector SPDR ETF - US ETF Option Call Option (XLF)
Tesla Inc - US Equity (TSLA)
Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)
Meta Platforms Inc - US Equity (META)
Taiwan Semiconductor Manufacturing Co Ltd - US Depository Receipt (TSM)
Alibaba Group Holding Ltd - US Depository Receipt (BABA)
Amazon.Com Inc - US Equity (AMZN)

View all positions for Tudor Investment Corporation

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Vivo Capital
BlackRock
Vanguard Group
Enavate Sciences GP
BVF
Vanguard Capital Management
State Street Corporation
Adage Capital Partners GP
Deerfield Management Company
Geode Capital Management
Blue Owl Capital Holdings
Rock Springs Capital Management

View all funds holding Compass Therapeutics